What does an FEV1/FVC ratio of 74.6% and a FEF25‑75 of 2.89 L/s indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Interpretation of FEV1/FVC 74.6% and FEF25-75 2.89 L/s

Your spirometry shows a borderline-to-normal FEV1/FVC ratio of 74.6% that does not meet criteria for airflow obstruction, but the reduced FEF25-75 suggests possible early small airway disease that may not yet be clinically significant.

Understanding Your FEV1/FVC Ratio

  • The FEV1/FVC ratio of 74.6% falls above the diagnostic threshold for obstruction, which is defined as <70% by fixed-ratio criteria or below the 5th percentile using age-adjusted reference values 1, 2.

  • This ratio is technically normal for most adults, as healthy adults should maintain an FEV1/FVC >70-80% 1.

  • However, age matters significantly in interpretation: If you are elderly (>70 years), this ratio is clearly normal, as the lower limit can drop to 65% in this age group 3. If you are young (<40 years), a ratio of 74.6% may actually represent mild obstruction that the fixed 70% cutoff misses 4, 5.

  • The fixed 70% threshold misidentifies nearly half of abnormal younger adults as normal and misidentifies approximately one-fifth of normal older adults as abnormal 5.

Understanding Your FEF25-75 Value

  • The FEF25-75 of 2.89 L/s reflects mid-expiratory flow and is thought to be sensitive for detecting early small airway disease 6.

  • A reduced FEF25-75 with preserved FEV1/FVC suggests possible early small airway involvement, manifesting as slowing in the terminal portion of the spirogram 6.

  • However, abnormalities in mid-range flow measurements are not specific for small airway disease in individual patients 6.

  • In cystic fibrosis populations, FEF25-75 detected obstruction in 31% of cases with normal FEV1, though FEV1/FVC ratio was more sensitive at 72% 7.

Clinical Significance and Next Steps

Without knowing your absolute FEV1 value, FVC value, symptoms, smoking history, and age, definitive classification is impossible, but here is the algorithmic approach:

If You Are Symptomatic (dyspnea, cough, wheezing):

  • Post-bronchodilator spirometry is mandatory using 400 mcg salbutamol, with reassessment 15 minutes later 2, 8.

  • A positive bronchodilator response (≥12% AND ≥200 mL improvement in FEV1 and/or FVC) suggests reversible airway disease like asthma 1, 8.

  • Consider measuring fractional exhaled nitric oxide (FeNO) to assess for eosinophilic airway inflammation if asthma is suspected 1.

  • If symptoms persist despite normal spirometry, consider bronchial provocation testing through referral to a pulmonologist 1.

If You Are Asymptomatic:

  • No routine pharmacotherapy is recommended for asymptomatic patients with borderline spirometry 2.

  • Serial spirometry should be performed to monitor for progression, as changes >200 mL in FEV1 are clinically significant 2.

Critical Age-Based Interpretation:

  • If you are <40 years old: Your ratio of 74.6% may represent true mild obstruction that requires age-adjusted reference values (5th percentile method) for accurate diagnosis 4, 5.

  • If you are >70 years old: Your ratio of 74.6% is definitively normal, and ratios down to 65% should be considered normal in this age group 3.

Common Pitfalls to Avoid

  • Do not diagnose obstruction based on FEF25-75 alone, as it has high variability and poor specificity 6.

  • Do not ignore the clinical context: Spirometry must be interpreted alongside symptoms, smoking history, occupational exposures, and physical examination findings 6.

  • Do not use pre-bronchodilator values to diagnose COPD, as post-bronchodilator testing is mandatory 2, 8.

  • Do not assume a "normal" FEV1/FVC excludes all airway disease, as 75% of tests with normal FEV1 showed other abnormalities in one study 7.

Related Questions

What is the interpretation of spirometry findings showing a Forced Expiratory Volume (FEV1) to Forced Vital Capacity (FVC) ratio of 81% post-Ventolin (albuterol), with an FVC of 67% and FEV1 of 69%, and a Peak Expiratory Flow (PEF) of 76%?
How should I interpret spirometry showing an FEV1/FVC ratio of 69%, FEV1 64% of predicted, and FVC 70% of predicted, and what management is recommended?
What is the recommended management for a 74-year-old male smoker with a 30-pack-year smoking history and spirometry showing an FEV1/FVC ratio of 73% (above obstruction threshold), FEV1 75% predicted, and FVC 77% predicted?
What do the lung function results (FEV1 55% predicted, vital capacity 62% predicted, total lung capacity 59% predicted) indicate?
What is the interpretation of pulmonary function test results showing a forced expiratory volume in 1 second (FEV1) of 82% predicted, a forced vital capacity (FVC) of 71% predicted, and an FEV1/FVC ratio of 87%?
What does a markedly low haptoglobin with elevated ferritin indicate and how should it be evaluated and managed?
Can a patient recovering from diabetic ketoacidosis develop refeeding syndrome?
Does amoxicillin require renal dose adjustment in a patient with a solitary kidney?
What laboratory tests should be ordered to evaluate adrenal function, including assessment for adrenal insufficiency and excess?
What are the treatment options for a 2.3 cm renal mass that increased from 1.6 cm, possibly renal cell carcinoma, in an otherwise healthy adult who is medically fit for definitive therapy?
For a bipolar patient on long‑acting aripiprazole injection (Abilify Maintena 400 mg every 4 weeks) with an oral aripiprazole 15 mg daily supplement for one week who now has breakthrough mania, and who has failed lithium and cannot tolerate valproate (Depakote), should the injection interval be extended to every two months or what is the appropriate management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.